Search Results

Active, currently enrolling    Who can join   

EMBER-4: A Randomized, Open-Label, Phase 3 Study of Adjuvant Imlunestrant vs Standard Adjuvant Endocrine Therapy in Patients who have Previously Received 2 to 5 years of Adjuvant Endocrine Therapy for ER+, HER2- Early Breast Cancer with an Increased Risk of Recurrence

Keywords: Oncology (Adult);
Study Type: INTERVENTIONAL   |  Region: Hawaii

---

Enrollment complete    Who can join   

BO41843: A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY EVALUATING THE EFFICACY AND SAFETY OF GDC-9545 COMBINED WITH PALBOCICLIB COMPARED WITH LETROZOLE COMBINED WITH PALBOCICLIB IN PATIENTS WITH ESTROGEN RECEPTOR-POSITIVE, HER2-NEGATIVE LOCALLY ADVANCED OR METASTATIC BREAST CANCER

Keywords: Oncology (Adult);
Study Type: INTERVENTIONAL   |  Region: Hawaii

---

Active, currently enrolling    Who can join   

EXActDNA-003 / NSABP B-64: Breast Cancer Clinical Validation Study to Predict Recurrence of High-Risk Early Breast Cancer Treated With Neoadjuvant Therapy Using a Bespoke Circulating Tumor DNA Assay to Detect Molecular Residual Disease

Keywords: Oncology (Adult);Breast Cancer; ctDNA; Neoplasms by Site; Neoplasms; Breast…
Study Type: OBSERVATIONAL   |  Region: California - Northern

---

Active, currently enrolling    Who can join   

A Phase III Trial of One vs. Two Years of Maintenance Olaparib, With or Without Bevacizumab, in Patients With BRCA1/2 Mutated or Homologous Recombination Deficient (HRD+) Ovarian Cancer Following Response to First Line Platinum-Based Chemotherapy

Keywords: Ovarian Neoplasms, Endocrine Gland Neoplasms, Neoplasms by Site, Neoplasms,…
Study Type: INTERVENTIONAL   |  Region: California - Northern

---

Active, currently enrolling    Who can join   

Perioperative Versus Adjuvant Systemic Therapy in Patients With Resectable Non-Small Cell Lung Cancer - PROSPECT LUNG

Keywords: Lung Neoplasms, Respiratory Tract Neoplasms, Thoracic Neoplasms, Neoplasms by…
Study Type: INTERVENTIONAL   |  Region: California - Northern

---

Active, currently enrolling    Who can join   

National Liver Cancer Screening Trial

Keywords: Hepatocellular carcinoma surveillance; GALAD; Alpha Fetoprotein; Oncology…
Study Type: INTERVENTIONAL   |  Region: California - Northern

---

Active, currently enrolling    Who can join   

OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy With Checkpoint Inhibitor Therapy

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: INTERVENTIONAL   |  Region: California - Northern

---

Enrollment complete    Who can join   

A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared to Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women With Hormone Receptor Positive Breast Cancer

Keywords: Oncology (Adult); NSABP B-42; Breast Cancer; Breast Neoplasms; Neoplasms by…
Study Type: INTERVENTIONAL   |  Region: California - Northern

---

Enrollment complete    Who can join   

A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High Dose Interferon a-2b for Resected High Risk Melanoma

Keywords: Oncology (Adult); Oncology (Pediatrics); E1609 Melanoma; Neuroendocrine…
Study Type: INTERVENTIONAL   |  Region: California - Northern

---

Enrollment complete    Who can join   

A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab or Placebo in Patients With Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer

Keywords: Oncology (Adult); E5103; Breast Cancer;
Study Type: INTERVENTIONAL   |  Region: California - Northern

---